Laplace Interventional
Plymouth, US · Founded 2020 · 20 employees on LinkedIn · 3 known investors
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
Founders & leadership
Laplace Interventional was founded in 2020 by Ramji Iyer.
RI
Ramji IyerinFounder and CEO
Board
JH
Jenny H. BarbaBoard director
TM
Todd MortierBoard director
CM
Colin MorrisonBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$42M disclosed across 3 rounds · 2021–2025
▶$21.2MraisedFeb 2025 · 6 investors · Other Health CareRule 506(b)
▶$21.2MraisedFeb 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jenny H. BarbaDirector
- Todd MortierDirector
- Colin MorrisonDirector
- Ramji IyerExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $21.2M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$12.9MraisedJul 2023 · 9 investors · Other Health CareRule 506(b)
▶$12.9MraisedJul 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jenny BarbaDirector
- Ramji IyerExecutive Officer, Director
- Todd MortierDirector
- William DaiDirector
- Offering amount
- $12.9M
- Amount sold
- $12.9M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$7.9MraisedSep 2021 · 8 investors · Other Health CareRule 506(b)
▶$7.9MraisedSep 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ramji IyerExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- Minimum investment
- $25K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Edwards Lifesciences5 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Vumedi4 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
TipRanks4 shared keywordsFinancial analysis and stock research platform.
Companies competing with Laplace Interventional for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Laplace Interventional do?
- Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
- Who founded Laplace Interventional?
- Laplace Interventional was founded by Ramji Iyer in 2020.
- Who are Laplace Interventional's investors?
- Laplace Interventional's investors include Aphelion Capital, gener8tor, ShangBay Capital LLC.
- How much funding has Laplace Interventional raised?
- Laplace Interventional has disclosed $42M raised across 3 rounds.
- Where is Laplace Interventional headquartered?
- Laplace Interventional is headquartered in Plymouth, US.